National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 338851

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 338851
VAERS Form:
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.


Changed on 5/13/2013

VAERS ID: 338851 Before After
VAERS Form:
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTHB5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 UN / UN
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.


Changed on 9/14/2017

VAERS ID: 338851 Before After
VAERS Form:(blank) 1
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 0 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.


Changed on 2/14/2018

VAERS ID: 338851 Before After
VAERS Form:1
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.


Changed on 6/14/2018

VAERS ID: 338851 Before After
VAERS Form:1
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.


Changed on 8/14/2018

VAERS ID: 338851 Before After
VAERS Form:1
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.


Changed on 9/14/2018

VAERS ID: 338851 Before After
VAERS Form:1
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.


Changed on 10/14/2018

VAERS ID: 338851 Before After
VAERS Form:1
Age:0.3
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2009-01-29
Entered:2009-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Diarrhoea, Haematochezia, Intussusception, Vomiting, Enema administration

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA03564

Write-up: Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ. This report was part of a post-marketing surveillance study. The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception. The patient was hospitalized on 30-SEP-2007. Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception. The patient was discharged home. Event was 53 days post dose 1 of ROTATEQ. Intussusception was determined to be an other important medical event. No further information is available.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=338851&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166